Improving Clinical Manufacturing of IL-15 Activated Cytokine-Induced Killer (CIK) Cells

Cytokine-induced killer (CIK) cells are an immunotherapeutic approach to combat relapse following allogeneic hematopoietic stem cell transplantation (HSCT) in acute leukemia or myelodysplastic syndrome (MDS) patients. Prompt and sequential administration of escalating cell doses improves the efficac...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Immunol
Main Authors: Bremm, Melanie, Pfeffermann, Lisa-Marie, Cappel, Claudia, Katzki, Verena, Erben, Stephanie, Betz, Sibille, Quaiser, Andrea, Merker, Michael, Bonig, Halvard, Schmidt, Michael, Klingebiel, Thomas, Bader, Peter, Huenecke, Sabine, Rettinger, Eva
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2019
Assuntos:
Immunology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6554420/
https://ncbi.nlm.nih.gov/pubmed/31214182
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2019.01218
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados